Popular genetics-testing company 23andMe is partnering with drug giant GlaxoSmithKline to use people's DNA to develop medical treatments, the company announced in a blog post yesterday (July 25). During the four-year collaboration, the London-based GlaxoSmithKline will use 23andMe's genetic database to zero in on possible targets and treatments for human disease. "The goal of the […]